Giovanni M. Di Zenzo
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 126 publications
Linagliptin is a risk factor for bullous pemphigoid associated with BP180-NC16A/BP230 seronegativity and milder severity: Evidence from a prospective case-control study supporting ECD-BP180 enzyme-linked immunosorbent assay in reducing diagnostic delay.
Journal: Journal of the American Academy of Dermatology
Published: February 16, 2026
Antigen-presenting cell phenotype of skin-infiltrating eosinophils in bullous pemphigoid patients.
Journal: European journal of dermatology : EJD
Published: January 29, 2026
A case series of immune checkpoint inhibitor-induced bullous pemphigoid successfully treated with dupilumab and evidence for the BP180 midportion epitope as a preferential autoantigenic target.
Journal: Frontiers in medicine
Published: January 28, 2026
Distinctive Reactivity to the C-terminal Epitope of BP180 Characterizes Immune Checkpoint Inhibitor-associated Bullous Pemphigoid, and an ELISA Based on the BP180 Ectodomain Enables Prompt Diagnosis in a Subset of Patients.
Journal: Acta dermato-venereologica
Published: January 09, 2026
Distinctive Reactivity to the C-terminal Epitope of BP180 Characterizes Immune Checkpoint Inhibitor-associated Bullous Pemphigoid, and an ELISA Based on the BP180 Ectodomain Enables Prompt Diagnosis in a Subset of Patients.
Journal: Acta dermato-venereologica
Published: January 09, 2026
Localized dominant dystrophic epidermolysis bullosa worsened by diabetes.
Journal: European journal of dermatology : EJD
Published: November 24, 2025
Bullous pemphigoid associated with canagliflozin intake.
Journal: Italian journal of dermatology and venereology
Published: October 03, 2025
Efficacy of JAK inhibitors in treating dominant dystrophic epidermolysis bullosa and alopecia areata.
Journal: Italian journal of dermatology and venereology
Published: October 03, 2025
BP230-Type Bullous Pemphigoid is a Rare Subset of Bullous Pemphigoid Associated With a Favorable Prognosis: A Retrospective Analysis From a Tertiary Referral Center.
Journal: International journal of dermatology
Published: September 16, 2025
Standardized indirect immunofluorescence-based detection of dermal-binding autoantibodies in pemphigoid diseases: a prospective international multicentre study.
Journal: The British journal of dermatology
Published: July 18, 2025
Autoantibodies to α6 Integrin Subunit Are Detected in a Cohort of Italian Oral Pemphigoid Patients.
Journal: International journal of dermatology
Published: May 05, 2025
Artificial Intelligence Software Changes Rare Disease Testing Strategy in Real Time: An International Case Series Using Face2Gene.
Journal: American journal of medical genetics. Part A
Published: April 29, 2025
Last Updated: 09/26/2026